切换至 "中华医学电子期刊资源库"

中华实验和临床感染病杂志(电子版) ›› 2026, Vol. 20 ›› Issue (01) : 10 -14. doi: 10.3877/cma.j.issn.1674-1358.2026.01.003

综述

幽门螺杆菌耐药与毒力基因分子检测方法研究进展
兰庆站1,2, 李波清2, 牟彤3, 卢志明1, 金炎1, 邵春红1,()   
  1. 1 250014 济南市,山东第一医科大学附属省立医院临床医学检验部
    2 264003 烟台市,滨州医学院基础医学院病原生物学教研室
    3 250014 济南市,山东第一医科大学附属省立医院消化内科
  • 收稿日期:2025-07-17 出版日期:2026-02-15
  • 通信作者: 邵春红
  • 基金资助:
    山东省自然科学基金项目(ZR2021MH214,ZR2025MS1331)

Research progress on molecular detection methods for resistance and virulence genes of Helicobacter pylori

Qingzhan Lan1,2, Boqing Li2, Tong Mu3, Zhiming Lu1, Yan Jin1, Chunhong Shao1,()   

  1. 1 Department of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250014, China
    2 Department of Pathogenic Biology, School of Basic Medical Sciences, Binzhou Medical University, Yantai 264003, China
    3 Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250014, China
  • Received:2025-07-17 Published:2026-02-15
  • Corresponding author: Chunhong Shao
引用本文:

兰庆站, 李波清, 牟彤, 卢志明, 金炎, 邵春红. 幽门螺杆菌耐药与毒力基因分子检测方法研究进展[J/OL]. 中华实验和临床感染病杂志(电子版), 2026, 20(01): 10-14.

Qingzhan Lan, Boqing Li, Tong Mu, Zhiming Lu, Yan Jin, Chunhong Shao. Research progress on molecular detection methods for resistance and virulence genes of Helicobacter pylori[J/OL]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2026, 20(01): 10-14.

幽门螺杆菌是引起人体消化道疾病最重要的病原菌之一,已被世界卫生组织列为Ⅰ类致癌物,其精准检测对临床诊疗具有重要意义。目前,临床常规诊断方法众多,以血清学抗体检测法、13C/14C尿素呼气试验法、微需氧培养法以及组织学染色法等常用,然而随着抗菌药物的过度使用,其耐药现象日益严重,传统检测方法已不能完全满足个体化诊疗需求,分子检测技术通过靶向检测耐药与毒力基因已成为临床诊疗与科研攻关迫切需求的重要工具,为临床提供了新的解决方案。本文对幽门螺杆菌分子检测方法研究进展进行综述,探讨其临床应用价值及技术局限性,为幽门螺杆菌感染个体化精准诊疗方案的选择提供理论依据。

Helicobacter pylori is one of the most important pathogens causing human gastrointestinal diseases and has been classified as a Group 1 carcinogen by the World Health Organization (WHO). Accurate detection of Helicobacter pylori is of great significance for clinical diagnosis and treatment. Currently, a variety of routine clinical diagnostic methods are available, with serological antibody detection, 13C/14C urea breath test (UBT), microaerophilic culture and histological staining being the most commonly used. However, due to the overuse of antibacterial agents, Helicobacter pylori drug resistance has become increasingly prevalent, rendering traditional detection methods inadequate to fully meet the demands of personalized medicine. Molecular detection technologies, which target drug resistance and virulence genes, have emerged as crucial tools urgently required for clinical practice and scientific research, providing novel solutions for clinical management. This review summarizes the research progress of molecular detection methods for Helicobacter pylori, discusses their clinical application value and technical limitations, and aims to provide a theoretical basis for the selection of individualized and precise diagnosis and treatment strategies for Helicobacter pylori infection.

[1]
Li A, AlHussaini KI. Helicobacter pylori: A contemporary perspective on pathogenesis, diagnosis and treatment strategies[J]. Microorganisms,2024,12(1):222.
[2]
Li Y, Choi H, Leung K, et al. Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis[J]. Lancet Gastroenterol Hepatol,2023,8(6):553-564.
[3]
Xie L, Liu GW, Liu YN, et al. Prevalence of Helicobacter pylori infection in China from 2014-2023: A systematic review and Meta-analysis[J]. World J Gastroenterol,2024,30(43):4636-4656.
[4]
Ren S, Cai P, Liu Y, et al. Prevalence of Helicobacter pylori infection in China: A systematic review and meta-analysis[J]. J Gastroenterol Hepatol,2022,37(3):464-470.
[5]
Nguyen TMN, Tran VH, Ha TMT. Helicobacter pylori cagA, vacA, and iceA genotypes and clinical outcomes: a cross-sectional study in central Vietnam[J]. Braz J Microbiol,2024,55(2):1393-1404.
[6]
Sukri A, Hanafiah A, Mohamad Zin N, et al. Epidemiology and role of Helicobacter pylori virulence factors in gastric cancer carcinogenesis[J]. APMIS,2020,128(2):150-161.
[7]
Backert S, Linz B, Tegtmeyer N. Helicobacter pylori-induced host cell DNA damage and genetics of gastric cancer development[J]. Curr Top Microbiol Immunol,2023,444:185-206.
[8]
Alipour M. Molecular Mechanism of Helicobacter pylori-Induced Gastric Cancer[J]. J Gastrointest Cancer,2021,52(1):23-30.
[9]
Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis[J]. Gut,2015,64(9):1353-1367.
[10]
Liao W, Wang J, Li Y. Natural products based on Correa’s cascade for the treatment of gastric cancer trilogy: Current status and future perspective[J]. J Pharm Anal,2025,15(2):101075.
[11]
Godbole G, Mégraud F, Bessède E. Review: Diagnosis of Helicobacter pylori infection[J]. Helicobacter,2020,25(Suppl 1):e12735.
[12]
Šeligová B, Lukáč Ľ, Bábelová M, et al. Diagnostic reliability of nested PCR depends on the primer design and threshold abundance of Helicobacter pylori in biopsy, stool, and saliva samples[J]. Helicobacter,2020,25(2):e12680.
[13]
Al Qady A, Aldhaleei W, Salih M, et al. Accuracy of fecal polymerase chain reaction testing in Clarithromycin-resistant Helicobacter Pylori: A systematic review and Meta-analysis[J]. Clin Transl Gastroenterol,2025,16(2):e00792.
[14]
FitzGerald R, Sinha C, Yadegar A, et al. Helicobacter pylori virulence factor genotyping[J]. Methods Mol Biol,2021,2283:93-106.
[15]
中华医学会消化病学分会幽门螺杆菌学组. 第六次全国幽门螺杆菌感染处理共识报告(非根除治疗部分)[J]. 中华消化杂志,2022,42(5):289-303.
[16]
Li CL, Zhou K, Zhang YX, et al. Tailored therapy guided by genotypic resistance of clarithromycin and levofloxacin detected by polymerase chain reaction in the first-line treatment of Helicobacter pylori infection[J]. J Dig Dis,2024,25(1):36-43.
[17]
Hoshina S, Kahn SM, Jiang W, et al. Direct detection and amplification of Helicobacter pylori ribosomal 16S gene segments from gastric endoscopic biopsies[J]. Diagn Microbiol Infect Dis,1990,13(6):473-479.
[18]
崔玉峰, 林毅军, 王志民. 幽门螺杆菌分子检测技术研究进展[J/OL]. 中华实验和临床感染病杂志(电子版),2024,18(5):257-262.
[19]
林垲皓, 黄丽芳, 李爱民. 幽门螺杆菌分子耐药检测指导的个体化治疗研究进展[J]. 中国医学创新,2023,20(8):173-178.
[20]
Singh C, Roy-Chowdhuri S. Quantitative Real-Time PCR: Recent Advances[J]. Methods Mol Biol,2016,1392:161-176.
[21]
Wang L, Lai JX, Si YT, et al. Quantitative polymerase chain reaction (qPCR)-based rapid diagnosis of Helicobacter pylori infection and antibiotic resistance[J]. J Vis Exp,2023,197.
[22]
石建玲, 程波, 刘珊, 等. 基于TaqMan探针的幽门螺杆菌实时荧光定量PCR检测方法的建立[J]. 中国实验诊断学,2013,17(6):986-989.
[23]
Alarcón-Millán J, Bonilla-Delgado J, Fernández-Tilapa G, et al. Helicobacter pylori virulence factors and Clarithromycin resistance-associated mutations in Mexican patients[J]. Pathogens,2023,12(2):234.
[24]
Chen SY, Chou YC, Huang JW, et al. Comparison of manual and automated nucleic acid extraction methods in virus transport medium[J]. Clin Lab,2021,67(12):210443.
[25]
钟泽澄, 王进, 张师音. 多重PCR技术研究进展[J]. 生物工程学报,2020,36(2):171-179.
[26]
Hasukić I, Salkić N, Tihić N, et al. Helicobacter pylori resistance to clarithromycin and quinolones in patients with dyspepsia in Tuzla Canton, Bosnia and Herzegovina[J]. Med Glas (Zenica),2023,20(2):10.
[27]
Kishk RM, Soliman NM, Anani MM, et al. Genotyping of Helicobacter pylori virulence genes cagA and vacA: regional and national study[J]. Int J Microbiol,2021,2021:5540560.
[28]
吴科明. 多重PCR技术在致病菌检测中的应用进展[J]. 医药前沿,2018,8(11):381-383.
[29]
McGinn S, Gut IG. DNA sequencing-spanning the generations[J]. N Biotechnol,2013,30(4):366-372.
[30]
Heather JM, Chain B. The sequence of sequencers: The history of sequencing DNA[J]. Genomics,2016,107(1):1-8.
[31]
Arboleda VA, Xian RR. An overview of DNA analytical methods[J]. Methods Mol Biol,2019,1897:385-402.
[32]
张远远, 潘科, 糜孟衡, 等. 黔南州和贵阳市幽门螺杆菌临床菌株的耐药性, 基因多样性及其与疾病的关系[J]. 中国人兽共患病学报,2024,40(1):46-55.
[33]
Dorado G, Gálvez S, Rosales TE, et al. Analyzing modern biomolecules: The revolution of nucleic-acid sequencing-review[J]. Biomolecules,2021,11(8):1111.
[34]
Saracino IM, Pavoni M, Zullo A, et al. Next generation sequencing for the prediction of the antibiotic resistance in Helicobacter pylori: A literature review[J]. Antibiotics (Basel),2021,10(4):437.
[35]
何承志, 张小燕, 郜恒骏. 幽门螺杆菌对六种抗生素的耐药基因测序结果分析[J/OL]. 中华消化病与影像杂志(电子版),2025,15(6):604-609.
[36]
Hu T, Chitnis N, Monos D, Dinh A. Next-generation sequencing technologies: An overview[J]. Hum Immunol,2021,82(11):801-811.
[37]
Searle B, Müller M, Carell T, et al. Third-generation sequencing of epigenetic DNA[J]. Angew Chem Int Ed Engl,2023,62(14):e202215704.
[38]
Hu L, Zeng X, Ai Q, et al. Long-read-and short-read-based whole-genome sequencing reveals the antibiotic resistance pattern of Helicobacter pylori[J]. Microbiol Spectr,2023,11(3):e0452222.
[39]
Tissera K, Kim MA, Lai J, et al. Characterization of East-Asian Helicobacter pylori encoding Western EPIYA-ABC cagA[J]. J Microbiol,2022,60(2):207-214.
[40]
赵欣, 肖迪. 质谱技术在核酸检测分析中的研究进展[J]. 中华预防医学杂志,2024,58(1):98-106.
[41]
Ilina EN, Borovskaya AD, Serebryakova MV, et al. Application of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for the study of Helicobacter pylori[J]. Rapid Commun Mass Spectrom,2010,24(3):328-334.
[42]
Cardos AI, Maghiar A, Zaha DC, et al. Evolution of diagnostic methods for Helicobacter pylori infections: from traditional tests to high technology, advanced sensitivity and discrimination tools[J]. Diagnostics (Basel),2022,12(2):508.
[43]
Gao X, Tan BH, Sugrue RJ, et al. MALDI mass spectrometry for nucleic acid analysis[J]. Top Curr Chem,2013,331:55-77.
[44]
许蕴, 李赟, 张晓丽, 等. 飞行时间质谱核酸检测技术在临床检测中的应用[J]. 中华检验医学杂志,2019,42(8):694-699.
[45]
Bulyk ML. DNA microarray technologies for measuring protein-DNA interactions[J]. Curr Opin Biotechnol,2006,17(4):422-430.
[46]
Ranjbar R, Ebrahimi A, Sahebkar A. Helicobacter pylori infection: Conventional and molecular strategies for bacterial diagnosis and antibiotic resistance testing[J]. Curr Pharm Biotechnol,2023,24(5):647-664.
[47]
Song Y, Dou F, Zhou Z, et al. Microarray-based detection and clinical evaluation for Helicobacter pylori resistance to Clarithromycin or Levofloxacin and the genotype of CYP2C19 in 1083 patients[J]. Biomed Res Int,2018,2018:2684836.
[48]
杨莉丽, 邹傲, 吴慧华, 等. 基于可视化基因芯片技术指导幽门螺杆菌个体化治疗的临床研究[J]. 分子诊断与治疗杂志,2021,13(3):449-452.
[49]
周成林, 杨洋, 董苏荣, 等. 幽门螺杆菌的耐药机制及基因检测研究进展[J]. 中华检验医学杂志,2020,43(12):1243-1247.
[1] 宋葳, 周文智, 唐立, 姜舟, 杨柳. 免疫骨骼发育不良伴神经发育异常2例并文献复习[J/OL]. 中华妇幼临床医学杂志(电子版), 2025, 21(05): 598-604.
[2] 戚红霞, 张李娜, 王璐璐, 黄夕夏, 刘锋华. 胃息肉合并结肠息肉患者临床特征及其与不同亚型幽门螺杆菌感染的关系[J/OL]. 中华实验和临床感染病杂志(电子版), 2026, 20(01): 54-64.
[3] 安宁, 陈健, 张京伟, 习一清. 长链非编码RNA 乳腺癌抗雌激素耐药基因4 在常见肿瘤进展中的作用[J/OL]. 中华普通外科学文献(电子版), 2025, 19(03): 203-208.
[4] 曹颖仪, 戴立廷, 赖艳榕, 冯文强, 袁培博, 陈定强. 耐碳青霉烯类肺炎克雷伯菌特征及致病机制研究[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(03): 423-428.
[5] 苟亚妮, 申群斌, 张丽, 卢佳佳. 幽门螺杆菌根除治疗与肠道菌群失调的互作机制、挑战与干预策略探究[J/OL]. 中华结直肠疾病电子杂志, 2025, 14(04): 359-363.
[6] 中国医师协会结直肠肿瘤专业委员会免疫学组. 结直肠癌免疫治疗专家共识(2025版)[J/OL]. 中华结直肠疾病电子杂志, 2025, 14(04): 289-298.
[7] 何承志, 张小燕, 郜恒骏. 幽门螺杆菌对六种抗生素的耐药基因测序结果分析[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(06): 604-609.
[8] 李朋娟, 李红阁, 张秦俊. 健脾化湿汤加减治疗脾胃湿热型幽门螺杆菌相关性慢性非萎缩性胃炎的临床研究[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(06): 599-603.
[9] 刘麒, 陈萍, 曹筱璇, 周梅, 张斌强, 朱文博. 幽门螺杆菌感染对帕金森病患者疾病进展及外周炎症因子、凝血功能指标特征的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(03): 262-266.
[10] 杨丽, 唐沛玲, 罗德兰, 张凤, 兰艳, 童安琴, 钟玉全. 白光及放大内镜下京都胃炎新增幽门螺杆菌感染相关性内镜征象的应用观察[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(03): 245-249.
[11] 汤峥丽, 王芳, 王唯坚. 体检人群14C阳性诊治情况跟踪及影响因素分析[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(01): 65-68.
[12] 李芳芳, 刘晓红, 孙燕滨. 窄带成像技术在幽门螺杆菌感染胃早期癌变诊断中的价值[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(01): 29-33.
[13] 王一. 血清胃蛋白酶原检测在儿童幽门螺杆菌相关性胃炎中的临床研究[J/OL]. 中华临床医师杂志(电子版), 2025, 19(02): 140-144.
[14] 胡春财, 袁伟曦, 赖少芬, 魏楚洪, 余高平, 肖文玲, 尹小毛. 基于RAA-CRISPR-Cas12a检测肺炎克雷伯菌KPC型碳青霉烯酶基因方法的建立及评价[J/OL]. 中华临床实验室管理电子杂志, 2025, 13(03): 166-171.
[15] 严茹钰, 沈瀚, 曹小利. 全球屎肠球菌耐药基因分布、序列分型及流行特点分析[J/OL]. 中华临床实验室管理电子杂志, 2025, 13(01): 27-34.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?